Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul W H I Parren

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
Methods (San Diego, Calif.)|November 5, 2013
Mind the gapJanine Schuurman, Paul W H I Parren
Nature Cancer|September 11, 2024
Antibody avidity meets multiple myelomaSigrid R Ruuls, Paul W H I Parren
Protein Engineering, Design & Selection : PEDS|November 1, 2017
Celebrating Antibody TherapeuticsPaul W H I Parren, James S Huston
Science (New York, N.Y.)|November 16, 2016
Hitting Ebola, to the power of twoAran F Labrijn, Paul W H I Parren
Science (New York, N.Y.)|March 21, 2009
Immunology. Two-in-one designer antibodiesPaul W H I Parren, Dennis R Burton
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2007
Genetic vaccination: one-shot shopping for immediate and sustained protectionElmieke P J Boot, Paul W H I Parren
Mabs|September 8, 2012
Fab-arm exchange: what's in a name?Janine Schuurman, Aran F Labrijn, Paul W H I Parren
Mabs|June 17, 2017
Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and morePaul W H I Parren, Paul J Carter, Andreas Plückthun
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Therapeutic antibody gene transfer: an active approach to passive immunityJoost M Bakker, Wim K Bleeker, Paul W H I Parren
Nature Reviews. Drug Discovery|July 5, 2022
Avidity in antibody effector functions and biotherapeutic drug designSimone C Oostindie, Greg A Lazar, Janine Schuurman, et al.
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
Methods (San Diego, Calif.)|November 5, 2013
Mind the gapJanine Schuurman, Paul W H I Parren
Nature Cancer|September 11, 2024
Antibody avidity meets multiple myelomaSigrid R Ruuls, Paul W H I Parren
Protein Engineering, Design & Selection : PEDS|November 1, 2017
Celebrating Antibody TherapeuticsPaul W H I Parren, James S Huston
Science (New York, N.Y.)|November 16, 2016
Hitting Ebola, to the power of twoAran F Labrijn, Paul W H I Parren
Science (New York, N.Y.)|March 21, 2009
Immunology. Two-in-one designer antibodiesPaul W H I Parren, Dennis R Burton
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 22, 2007
Genetic vaccination: one-shot shopping for immediate and sustained protectionElmieke P J Boot, Paul W H I Parren
Mabs|September 8, 2012
Fab-arm exchange: what's in a name?Janine Schuurman, Aran F Labrijn, Paul W H I Parren
Mabs|June 17, 2017
Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and morePaul W H I Parren, Paul J Carter, Andreas Plückthun
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Therapeutic antibody gene transfer: an active approach to passive immunityJoost M Bakker, Wim K Bleeker, Paul W H I Parren
Nature Reviews. Drug Discovery|July 5, 2022
Avidity in antibody effector functions and biotherapeutic drug designSimone C Oostindie, Greg A Lazar, Janine Schuurman, et al.
Pageof 16